TOFACITINIB RIDUCE LE COMPLICANZE OPERATORIE RISPETTO AI BIOLOGICI IN CASO DI COLECTOMIA PER COLITE ULCEROSA. UN IMPORTANTE STUDIO MULTICENTRICO ITALIANO RETROSPETTIVO DA “AJG”.
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study Dragoni, Gabriele and the “TOFA-poSTOP” Study Group Abstract Background and aims: Patients with ulcerative colitis (UC) receiving immunosuppressive drugs are at substantial risk of colectomy. We aimed to assess the risk of post-operative complications…

